The periodontal pathogen Porphyromonas gingivalis cleaves apoB-100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation

Journal of Internal Medicine

Volumn 263, Issue 5, 2008, Pages 558-571

  Bengtsson, T ^a   Karlsson, H ^a   Gunnarsson, P ^a   Skoglund, C ^a   Elison, C ^a   Leanderson, P ^a   Lindahl, M ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Growth factors; Infection; Inflammation; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN M; GINGIPAIN R; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; DISEASE ASSOCIATION; LEUKOCYTE ACTIVATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS; CELL PROLIFERATION; FIBROBLASTS; HUMANS; LIPOPROTEINS, LDL; PORPHYROMONAS GINGIVALIS; PROTEIN CARBONYLATION; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 42149133781     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01917.x     Document Type: Article

References (63)

1. Meyer D, Fives-Taylor P. Oral pathogens: from dental plaque to cardiac disease. Curr Opin Microbiol 1998 1 : 88 95.
2. Genco RJ. Periodontal disease and risk for myocardial infection and cardiovascular disease. Cardiovasc Rev Rep 1998 19 : 34 40.
3. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001 21 : 1816 22.
4. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992 63 : 322 31.
5. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000 71 : 1554 60.
6. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr., Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005 25 : e17 8.
7. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontology 2000 20 : 168 238.
8. Waddington RJ, Moseley R, Embery G. Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 2000 6 : 138 51.
9. Tsai CC, Chen HS, Chen SL et al. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005 40 : 378 84.
10. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989 321 : 1196 7.
11. Carr A, Frei B. Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C. Biol Chem 2002 383 : 627 36.
12. Gorog P, Kovacs I. Lipid peroxidation by activated platelets: a possible link between thrombosis and atherogenesis. Atherosclerosis 1995 115 : 121 8.
13. Berliner JA, Hencke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996 20 : 707 27.
14. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006 185 : 219 26.
15. Memon RA, Staprans I, Noor M et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000 20 : 1536 42.
16. Kälvegren H, Bylin H, Leanderson P, Richter A, Grenegård M, Bengtsson T. Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Thromb Haemost 2005 94 : 327 35.
17. Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988 8 : 79 87.
18. Tertov VV, Bittolo-Bon G, Sobenin IA, Cazzolato G, Orekhov AN, Avogaro P. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Exp Mol Pathol 1995 62 : 166 72.
19. Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation 1996 94 : 1698 704.
20. Herzberg MC, MacFarlane GD, Liu P, Erickson PR. The platelet as an inflammatory cell in periodontal diseases. In : Genco RJ, Hamada S, Lehrer JR, McGhee JR, Mergenhagen S, eds. Molecular Pathogenesis of Periodontal Diseases. Washington, DC : ASM Press, 1994 247 55.
21. Pham K, Feik D, Hammond BF, Rams TE, Whitaker EJ. Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. Platelets 2002 13 : 21 30.
22. Katsuragi H, Ohtake M, Kurasawa I, Saito K. Intracellular production and extracellular release of oxygen radicals by PMNs and oxidative stress on PMNs during phagocytosis of periodontopathic bacteria. Odontology 2003 91 : 13 8.
23. Pentikäinen MO, Öörni K, Ala-Korpela M, Kovanen PT. Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima. J Intern Med 2000 247 : 359 70.
24. Torzewski M, Klouche M, Hock J et al. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 1998 18 : 369 78.
25. Viita H, Narvanen O, Yla-Herttuala S. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein. Life Sci 1999 65 : 783 93.
26. Bengtsson T, Grenegård M. Platelet-leukocyte interaction in whole blood. Scand J Clin Lab Invest 2002 62 : 1 12.
27. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005 5 : 551 65.
28. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005 5 : 1431 45.
29. Da Silva EL, Tsushida T, Terao J. Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglycosides. Arch Biochem Biophys 1998 349 : 313 20.
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 54.
31. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997 23 : 361 6.
32. Lindahl M, Stahlbom B, Svartz J, Tagesson C. Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis. Electrophoresis 1998 19 : 3222 9.
33. Görg A, Obermaier C, Boguth G et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000 21 : 1037 53.
34. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996 68 : 850 8.
35. Berg C, Hammarstrom S, Herbertsson H et al. Platelet-induced growth of human fibroblasts is associated with an increased expression of 5-lipoxygenase. Thromb Haemost 2006 96 : 652 9.
36. Miyakawa H, Honma K, Qi M, Kuramitsu HK. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J Periodontal Res 2004 39 : 1 9.
37. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991 266 : 2005 8.
38. Yan LJ, Traber MG, Packer L. Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal Biochem 1995 228 : 349 51.
39. Lourbakos A, Yuan YP, Jenkins AL et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 2001 97 : 3790 7.
40. Lourbakos A, Chinni C, Thompson P et al. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 1998 435 : 45 8.
41. Bodet C, Chandad F, Grenier D. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol 2006 143 : 50 7.
42. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004 84 : 1381 478.
43. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 2004 256 : 413 20.
44. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 2006 10 : 389 406.
45. Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987 262 : 3603 8.
46. Brown BE, Mahroof FM, Cook NL, Van Reyk DM, Davies MJ. Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins. Diabetologia 2006 49 : 775 83.
47. Edelstein C, Nakajima K, Pfaffinger D, Scanu AM. Oxidative events caused degradation of apo B-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins. J Lipid Res 2001 42 : 1664 70.
48. Hashimoto M, Kadowaki T, Tsukuba T, Yamamoto K. Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure. J Biochem (Tokyo) 2006 140 : 713 23.
49. Xu N, Dahlbäck B. A novel human apolipoprotein (apoM). J Biol Chem 1999 274 : 31286 90.
50. Karlsson H, Lindqvist H, Tagesson C, Lindahl M. Characterization of apolipoprotein M isoforms in low-density lipoprotein. J Proteome Res 2006 5 : 2685 90.
51. Duan J, Dahlback B, Villoutreix BO. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett 2001 499 : 127 32.
52. Zhang XY, Dong X, Zheng L et al. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem 2003 105 : 67 72.
53. Xu N, Zhang XY, Dong X, Ekstrom U, Ye Q, Nilsson-Ehle P. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. Biochem Biophys Res Commun 2002 292 : 944 50.
54. Luo G, Zhang X, Nilsson-Ehle P, Xu N. Apolipoprotein M. Lipids Health Dis 2004 3 : 21.
55. Luo G, Hurtig M, Zhang X, Nilsson-Ehle P, Xu N. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells. Biochim Biophys Acta 2005 1734 : 198 202.
56. Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 2005 11 : 418 22.
57. Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlback B. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 2006 47 : 33 43.
58. Faber K, Axler O, Dahlback B, Nielsen LB. Characterization of apoM in normal and genetically modified mice. J Lipid Res 2004 45 : 1272 8.
59. Zettler ME, Prociuk MA, Austria JA, Massaeli H, Zhong G, Pierce GN. OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol Heart Circ Physiol 2003 284 : H644 53.
60. Klouche M, Rose-John S, Schmiedt W, Bhakdi S. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000 101 : 1799 805.
61. Zettler ME, Prociuk MA, Austria JA, Zhong G, Pierce GN. Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins. Arterioscler Thromb Vasc Biol 2004 24 : 727 32.
62. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors. Arterioscler Thromb Vasc Biol 1998 18 : 738 46.
63. Mander EL, Dean RT, Stanley KK, Jessup W. Apolipoprotein B of oxidized LDL accumulates in the lysosomes of macrophages. Biochim Biophys Acta 1994 1212 : 80 92.